SCHEMBL1643436

SCHEMBL1643436

C=C(CCCCCCC)C(=O)O.C=C(CCCCCCCC)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 7/20 0.58
▸ PPARG P37231 7/20 0.58
▸ PPARD Q03181 7/20 0.58
▸ PPARA Q07869 7/20 0.58
▸ HDAC11 Q96DB2 5/20 0.58
▸ TSHR P16473 4/20 0.58
▸ PTPN1 P18031 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ TLR2 O60603 2/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ FABP4 P15090 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ SLC22A6 Q4U2R8 1/20 0.58
▸ SLC22A8 Q8TCC7 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ ESR1 P03372 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ PDE4A P27815 1/20 0.58
▸ PDE3A Q14432 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19124533 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11046278 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1923246 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3433544 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5710548 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7179029 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7158121 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5710638 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL27052 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3424245 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110097294-A1 HIGHLY FOAMING COMPOSITION RHODIA OPERATIONS (FR) 2011-04-28 — — US disclosed
EP-2039338-A1 Highly foaming composition Rhodia Opérations (FR) 2009-03-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110097294-A1 HIGHLY FOAMING COMPOSITION PHOSPHO1, LIPA, SGMS2 GPR84 1128/4885PPARG 2493/4885PPARD 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback